|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/32 | |
| A61K 39/395 | |||
| A61K 31/395 | |||
| A61P 13/08 | |||
| A61P 35/00 |
| (11) | Number of the document | 2788380 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12813984.7 |
| Date of filing the European patent application | 2012-12-04 | |
| (97) | Date of publication of the European application | 2014-10-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/056949 |
| Date | 2012-12-04 |
| (87) | Number | WO 2013/084147 |
| Date | 2013-06-13 |
| (30) | Number | Date | Country code |
| 201161566890 P | 2011-12-05 | US |
| (72) |
ELIS, Winfried, DE
ETTENBERG, Seth, US
GARNER, Andrew Paul, US
HAUBST, Nicole, DE
HUANG, Xizhong, US
KUNZ, Christian Carsten Silvester, DE
REISINGER SPRAGUE, Elizabeth Anne, US
SHENG, Qing, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) |
| ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) |